Compare Sat Nusapersada Tbk (PTSN) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Sat Nusapersada Tbk vs Organon Pharma Indonesia Tbk. — how do they compare? Sat Nusapersada Tbk trades at Rp372 (market cap 1.58T, 27.88M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Sat Nusapersada Tbk is far larger — about 15.1× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| PTSN | SCPI | |
|---|---|---|
Market Cap | 1.58T | 104.4B |
Volume | 27.88M | — |
Lot | 278.82K | — |
Turnover | 9.98B | — |
Average Price | 357.92 | — |
Value | 9.98B | — |
Indicative Equilibrium Price | 372 | — |
Indicative Equilibrium Volume | 19.71K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Sat Nusapersada Tbk
Sat Nusapersada Tbk (the company) was established on Jun 1, 1990 based on Notaries Deed No. 5 and the deed of establishment was approved by the the Ministry of Justice dated Sept 18, 1991. The Company’s articles of association has been amended several times, most recently by notarial deed No. 14 of Fathiah Helmi, S.H., dated Aug 7, 2007, concerning public offering.
Read more on PTSN →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
